Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

07 October 2022: Clinical Research

Abnormal Expression of the LAG-3/FGL-1 Signaling Pathway in Patients with Early-Onset Preeclampsia

Yue Liang 1CDE , Yining Liu 1AB , Shan Wang 2AF , Yongzhong Gu 2AF , Ping Wang 2B , Jinlai Meng 12AEG*

DOI: 10.12659/MSM.937498

Med Sci Monit 2022; 28:e937498

Figure 2 LAG-3 expression by different peripheral T cell subsets in women with NP and early-onset PE. Flow cytometry was used to determine the expression of LAG-3 by peripheral CD3+ T (A), CD4+ T (B) and CD8+ T cells (C) in NP and early-onset PE. Statistical comparisons were made by unpaired t test. The solid bars represent the medians of 34 samples, the boxes indicate the interquartile ranges, and the lines show the most extreme observations. Differences were considered significant when the P value was equal to or less than 0.05. * P<0.05, ** P<0.01. NP – normal pregnancy; Early-onset PE – early-onset preeclampsia. FACSDIVA V6. software (BD Biosciences) and GraphPad Prism software, version 7 (GraphPad) were used to create the figures.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750